Last updated: March 18, 2026
Sponsor: Chinese PLA General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Thyroid Disease
Treatment
ultrasound-guided thermal ablation
Clinical Study ID
NCT06340945
S2023-761-01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- [1]confirmation of benign nodule status on two separate fine- needle aspiration (FNA) or core-needle biopsy (CNB) [2]no suspicious malignant features on ultrasoundexamination [3]report of cosmetic and/ or symptomatic problems or concern of nodulesgrowing rapidly or malignant transformation [4]refusal or ineligibility for surgery [5]follow-up time ≥6months
Exclusion
Exclusion Criteria:
follicular neoplasm or malignancy findings on biopsy
nodules with benign result on biopsy had suspicious of malignancy in US, includingmarked hypoechoic, ill-defined margins, taller-than-wide shape ormicrocalcifications
patients with cystic nodules
patients with contra-lateral vocal cord par- alysis
previous radiation to the head and neck
; follow- up time less than 6 months
Study Design
Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: ultrasound-guided thermal ablation
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
December 31, 2029
Connect with a study center
Chinese PLA General Hospital
Beijing,
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.